Europe

Obtain the latest insights on mesothelioma clinical trials in Europe. Should you be doing chemotherapy or holistic instead? Learn More

Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments | Updates

Novel Mesothelioma Treatment is Based on Marine-Derived Compound
ByAlex Strauss July 24, 2016March 16, 2017

A new drug based on a compound derived from sea creatures may make an effective second-line treatment for patients with malignant pleural…

Read More Novel Mesothelioma Treatment is Based on Marine-Derived Compound
Europe | Genetics | International | New Drugs | New Studies | Research | Treatments | Updates

Tests Reveal Potential New Gene Target for Mesothelioma Therapy
ByAlex Strauss July 12, 2016March 16, 2017

A gene known as P2X7R (or P2RX7) and the protein that it encodes may offer a novel target for a…

Read More Tests Reveal Potential New Gene Target for Mesothelioma Therapy
Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments | Updates

Mesothelioma Chemotherapy May Get a Boost from Leukemia Drug
ByAlex Strauss July 10, 2016March 16, 2017

There is new evidence that a drug designed to treat leukemia may help boost the effectiveness of the most popular…

Read More Mesothelioma Chemotherapy May Get a Boost from Leukemia Drug
Europe | International | Prognosis | Surgery | Treatments | Updates

Influences on Survival After Radical Mesothelioma Surgery
ByAlex Strauss July 3, 2016March 16, 2017

Yet another new study is raising questions about the advisability of radical surgery for people with malignant pleural mesothelioma. Reporting…

Read More Influences on Survival After Radical Mesothelioma Surgery
Biopsy | Diagnosis | Europe | International | Prevention | Radiation Therapy | Symptoms | Treatments | Updates

Most Mesothelioma Patients Don’t Need Preventive Radiotherapy after Pleural Intervention
ByAlex Strauss July 1, 2016March 16, 2017

Preventive radiotherapy may not be the best way to keep new tumors from growing at the site of pleural interventions…

Read More Most Mesothelioma Patients Don’t Need Preventive Radiotherapy after Pleural Intervention
Australia | Biomarkers | Diagnosis | Europe | International | Mesothelioma | New Studies | Prognosis | Research | Updates

Activin A: A New Biomarker for Mesothelioma Prognosis?
ByAlex Strauss June 26, 2016March 16, 2017

If you’re a mesothelioma patient, should you have your activin A level checked? A new study suggests that this protein…

Read More Activin A: A New Biomarker for Mesothelioma Prognosis?
Asbestos | Biomarkers | Diagnosis | Europe | International | Prognosis | Updates

Earlier Mesothelioma Diagnosis with MicroRNAs
ByAlex Strauss June 23, 2016March 16, 2017

Tiny non-coding bits of RNA could hold the key to identifying malignant mesothelioma earlier and potentially improving mesothelioma survival. That…

Read More Earlier Mesothelioma Diagnosis with MicroRNAs
Asbestos | Europe | International | New Studies | Prevention | Research | Updates

Could Asbestos Play a Role in Kidney Cancer as Well as Mesothelioma?
ByAlex Strauss June 17, 2016June 20, 2017

New facts are emerging about the potential role of asbestos, the primary cause of malignant mesothelioma, in the development of…

Read More Could Asbestos Play a Role in Kidney Cancer as Well as Mesothelioma?
Biological Therapy | Chemotherapy | Europe | Immunotherapy | International | Multi-Modality Therapy | New Drugs | Research | Treatments | Updates

New Immunotherapy Drug Works Synergistically to Fight Malignant Mesothelioma
ByAlex Strauss June 15, 2016March 16, 2017

The creators of a new kind of cancer drug based on an altered cold virus say it appears to work synergistically with…

Read More New Immunotherapy Drug Works Synergistically to Fight Malignant Mesothelioma
Biomarkers | Diagnosis | Europe | Immune Systems | International | Prognosis | Research | Updates

Protein May Be Key to Mesothelioma Prognosis
ByAlex Strauss May 29, 2016March 16, 2017

A protein that downregulates the immune system and has been linked to a number of autoimmune disorders may help doctors…

Read More Protein May Be Key to Mesothelioma Prognosis

1 (888) 378-1331

Europe

Novel Mesothelioma Treatment is Based on Marine-Derived Compound

Tests Reveal Potential New Gene Target for Mesothelioma Therapy

Mesothelioma Chemotherapy May Get a Boost from Leukemia Drug

Influences on Survival After Radical Mesothelioma Surgery

Most Mesothelioma Patients Don’t Need Preventive Radiotherapy after Pleural Intervention

Activin A: A New Biomarker for Mesothelioma Prognosis?

Earlier Mesothelioma Diagnosis with MicroRNAs

Could Asbestos Play a Role in Kidney Cancer as Well as Mesothelioma?

New Immunotherapy Drug Works Synergistically to Fight Malignant Mesothelioma

Protein May Be Key to Mesothelioma Prognosis

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES